KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential

Abstract Lung cancer remains a significant health challenge, characterized by aberrant tissue growth within the pulmonary system. Early carcinogenic events often involve genomic instability and the emergence of a mutator phenotype. In this study, we aimed to explore the mutator phenotype in 89 patie...

Descripció completa

Dades bibliogràfiques

Autors principals:	Metin Eser, Gulam Hekimoglu, Murat Hakki Yarar, Sezin Canbek, Melike Ozcelik
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2024-11-01
Col·lecció:	Scientific Reports
Matèries:	KRAS G12C mutation Non-small-cell lung cancer Sotorasib
Accés en línia:	https://doi.org/10.1038/s41598-024-75208-4
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!